Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$2.3B
Avg Funding
$92.2M
Cities
22

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Wayne, United States
$50.0M
raised

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$200.0M
raised

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fort Worth, United States
$11.0M
raised

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Hayward, United States
$250.0M
raised

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Watertown, United States
$450.0M
raised

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$50.0M
raised

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States
$200.0M
raised

Recursion Pharmaceuticals is a biotech company that develops a drug discovery platform and pipeline with machine learning.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Reno, United States
$5.0M
raised

Medical Aesthetics, Longevity, Anti-Aging, Regenerative Medicine, Wound Care, Human Collagen

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$25.0M
raised

Vir Biotechnology is an immunology company that develops products to treat and prevent infectious diseases and other serious conditions.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Needham, United States
$250.0M
raised

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Antonio, United States
$4.0M
raised

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lausanne, Switzerland
$86.6M
raised

ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Paris, France
$1.1M
raised

GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Dallas, United States
$4.0M
raised

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$110.0M
raised

Pyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cincinnati, United States
$12.9M
raised

Onconetix is a biotechnology company that focuses on research and development of universal flu vaccines.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Miramar Beach, United States
$1.5M
raised

HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bromma, Sweden
$3.1M
raised

OncoZenge develops better products for the supportive care of cancer patients.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$1.2M
raised

Calidi Biotherapeutics is a clinical-stage biotechnology company developing immunotherapies for cancer.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oakville, Canada
$7.0M
raised

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Irvine, United States
$172.5M
raised

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States
$4.0M
raised

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$400.0M
raised

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$2.5M
raised

Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Morgan Hill, United States
$2.9M
raised

Tenon Medical is a biotechnology company that optimizes SI joint surgical solutions.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked